Journal article
The Impact of Industry Funding on Randomized Controlled Trials of Biologic Therapies
Abstract
Background: There has been substantial interest from the pharmaceutical industry to study and develop new biologic agents. Previous studies outside of the biologics field have demonstrated that industry funding has the potential to impact the design and findings of clinical trials. The objective of this study was to evaluate the impact of industry funding on randomized controlled trials (RCTs) that investigated the efficacy of biologic …
Authors
Gazendam AM; Slawaska-Eng D; Nucci N; Bhatt O; Ghert M
Journal
Medicines, Vol. 9, No. 3,
Publisher
MDPI
DOI
10.3390/medicines9030018
ISSN
2305-6320